文献速递腹部技术与安全US

超声衰减系数和背向散射系数评估非酒精性脂肪性肝病的跨平台可重复性

Inter-platform reproducibility of ultrasonic attenuation and backscatter coefficients in assessing NAFLD.
PubMed 文献 · Eur Radiol · 2019-02-19

这项前瞻性研究纳入64例已知或疑似非酒精性脂肪性肝病成人,用两家厂商的临床超声平台同日行右肝叶扫描,以参考体模法计算衰减系数和背向散射系数。衰减系数跨平台组内相关系数0.77、logBSC为0.70,皮尔逊相关系数分别为0.81和0.80,作者认为两者跨平台可重复。

要点

  • 衰减系数跨平台组内相关系数0.77、皮尔逊相关系数0.81,logBSC分别为0.70和0.80。
  • 衰减系数均值两平台为0.90±0.13与0.94±0.15 dB/cm/MHz,logBSC为-30.6±5.0与-27.9±5.6 dB。
  • 衰减系数受试者内变异系数7%,95%一致性界限-0.21至0.13 dB/cm/MHz。

核心结论

  • 在已知或疑似非酒精性脂肪性肝病成人中,肝脏衰减系数和背向散射系数在两种不同超声平台间可重复。

研究设计与样本

  • 经机构审查委员会批准、符合HIPAA的前瞻性研究,纳入64例已知或疑似非酒精性脂肪性肝病参与者,同日用两家厂商的临床超声平台检查,由同一名受过培训的超声技师经侧方肋间入路在右肝叶多次采集数据,以参考体模法计算衰减系数和背向散射系数。

诊断标准与关键数值

  • 跨平台绝对一致性组内相关系数:衰减系数0.77、logBSC 0.70;皮尔逊相关系数:衰减系数0.81、logBSC 0.80;95%一致性界限:衰减系数-0.21至0.13 dB/cm/MHz、logBSC -9.48至3.98 dB;衰减系数受试者内变异系数7%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To assess inter-platform reproducibility of ultrasonic attenuation coefficient (AC) and backscatter coefficient (BSC) estimates in adults with known/suspected nonalcoholic fatty liver disease (NAFLD).

METHODS: This HIPAA-compliant prospective study was approved by an institutional review board; informed consent was obtained. Participants with known/suspected NAFLD were recruited and underwent same-day liver examinations with clinical ultrasound scanner platforms from two manufacturers. Each participant was scanned by the same trained sonographer who performed multiple data acquisitions in the right liver lobe using a lateral intercostal approach. Each data acquisition recorded a B-mode image and the underlying radio frequency (RF) data. AC and BSC were calculated using the reference phantom method. Inter-platform reproducibility was evaluated for AC and log-transformed BSC (logBSC = 10log10BSC) by intraclass correlation coefficient (ICC), Pearson's correlation, Bland-Altman analysis with computation of limits of agreement (LOAs), and within-subject coefficient of variation (wCV; applicable to AC).

RESULTS: Sixty-four participants were enrolled. Mean AC values measured using the two platforms were 0.90 ± 0.13 and 0.94 ± 0.15 dB/cm/MHz while mean logBSC values were - 30.6 ± 5.0 and - 27.9 ± 5.6 dB, respectively. Inter-platform ICC was 0.77 for AC and 0.70 for log-transformed BSC in terms of absolute agreement. Pearson's correlation coefficient was 0.81 for AC and 0.80 for logBSC. Ninety-five percent LOAs were - 0.21 to 0.13 dB/cm/MHz for AC, and - 9.48 to 3.98 dB for logBSC. The wCV was 7% for AC.

CONCLUSIONS: Hepatic AC and BSC are reproducible across two different ultrasound platforms in adults with known or suspected NAFLD.

KEY POINTS: • Ultrasonic attenuation coefficient and backscatter coefficient are reproducible between two different ultrasound platforms in adults with NAFLD. • This inter-platform reproducibility may qualify quantitative ultrasound biomarkers for generalized clinical application in patients with suspected/known NAFLD.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Han A, Zhang YN, Boehringer AS, et al. Inter-platform reproducibility of ultrasonic attenuation and backscatter coefficients in assessing NAFLD. Eur Radiol. 2019. PMID: 30783789. doi:10.1007/s00330-019-06035-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。